Strong support for tailored exercise in knee and hip osteoarthritis. Adapt activity to symptoms and medical context.
Read the source ↗THE EVIDENCE DESK · UPDATED OCTOBER 2026
What's promising.
What's proven.
What's mostly hype.
Every treatment has a story. Here are six starting points with a plain-language evidence assessment and links to primary authorities. This isn't an individualized recommendation.
Guidelines strongly recommend topical NSAIDs for knee osteoarthritis; appropriateness depends on your medications and risks.
Read the source ↗USPSTF recommends biennial mammography for average-risk people in the relevant screening population.
Read the source ↗Human benefit and safety remain unestablished; FDA has flagged possible safety risks and limited information.
Read the source ↗Some preparations show modest short-term benefit for some chronic pain outcomes; harms and individual risks matter.
Read the source ↗Screening without symptoms or risk factors can yield incidental findings and downstream procedures.
Read the source ↗Our labels: Established means supported by clinical practice evidence for specified indications; experimental means evidence or approval is incomplete; mixed means benefit and harm vary by population or product. These are editorial summaries, not clinical reviews.
Questions worth asking: What outcome was measured? How many people were studied? How long was follow-up? What were the adverse effects? Is the treatment approved for this condition?
Explore your prevention checklist ↗